Technology Name | Briefcase | Lead Researcher |
---|---|---|
Background
DNA mutations in mitochondrial proteins/enzymes (nuclear encoded) that may lead to disease are present in approximately 1 in 8,000 individuals.
Any treatment for mitochondrial diseases must be capable of targeting and crossing the ... More | Galski- Lorberboum Haya |